Dana Investment Advisors, Inc.

Position in TGTX — Tg Therapeutics, Inc.

CIK 1427514 BROOKFIELD, WI

Position in TGTX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,460,151

+$205,836 QoQ

Shares Held

43,954

+4.5% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 95.14037402739227.ToString("F0")% Shared 0.ToString("F0")% None 4.859625972607726.ToString("F0")%

Healthcare · as of Mar 31, 2026

Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. TGTX ranks #6 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	69,234	$13,822,568
2	REGN	Regeneron Pharmaceuticals, Inc.	8,397	$6,487,858
3	AXSM	Axsome Therapeutics, Inc.	26,379	$4,458,578
4	VKTX	Viking Therapeutics, Inc.	59,756	$1,944,460
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,197	$1,673,533
6	TGTX	Tg Therapeutics, Inc. This page	43,954	$1,460,151
7	ZYME	Zymeworks Inc.	56,107	$1,404,919
8	IONS	Ionis Pharmaceuticals Inc	18,487	$1,388,188

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,460,151	43,954	+4.5%	Shares	Sole	2026-05-14
2025-12-31	$1,254,315	42,077	+18.0%	Shares	Sole	2026-02-05
2025-09-30	$1,288,145	35,658	+26.0%	Shares	Sole	2025-11-10
2025-06-30	$1,018,409	28,297	-5.9%	Shares	Sole	2025-08-13
2025-03-31	$1,186,093	30,081	-20.1%	Shares	Sole	2025-05-15
2024-12-31	$1,133,265	37,650	+0.6%	Shares	Sole	2025-02-06
2024-09-30	$875,604	37,435	-0.7%	Shares	Sole	2024-11-13
2024-06-30	$670,380	37,683	-0.6%	Shares	Sole	2024-08-27
2024-03-31	$576,382	37,895	+82.6%	Shares	Sole	2024-05-15
2023-12-31	$354,478	20,754	-63.9%	Shares	Sole	2024-02-07
2023-09-30	$481,193	57,559	+57.1%	Shares	Sole	2023-11-15
2023-06-30	$909,814	36,627	-6.6%	Shares	Sole	2023-08-15
2023-03-31	$589,868	39,220	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.